Human IL-5 ELISA Set
| Code | Size | Price |
|---|
| 851.670.001 | 1 x 96 Discovery | £119.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Human
Regulatory Status: RUO
Application: Enzyme-Linked Immunosorbent Assay (ELISA)
Further Information
Assay Range:
7.8-250 pg/ml
Cross reaction:
No cross reactivity with other human cytokines
Description:
Diaclone ELISA Sets include capture and biotinylated detection antibody one standard per plate Streptavidin-HRP TMB and detailed procedure including buffer composition.
Detection Target:
IL-5
Incubation:
From sample to end 3h45
Reactivity:
Human
Research Area:
Cytokines / Growth Factors
Sample Size:
100 µl
Sample Types:
Serum Plasma Cell culture supernatant
Sensitivity:
5 pg/ml
Specificity:
Recognizes both natural and recombinant human IL-5
References
- Ghannam S. et al. J. Immunol.2010; 185(1): 302-312. Mesenchymal Stem Cells Inhibit Human Th17 Cell Differentiation and Function and Induce a T Regulatory Cell Phenotype. https://www.ncbi.nlm.nih.gov/pubmed/20511548
- Pecaric-Petkovic T. et al. Blood2009; 113(7): 1526-1534.. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33.. https://www.ncbi.nlm.nih.gov/pubmed/18955562
- Zhang Q. et al. Infect Immun.2006; 74(8): 4735-43.. Regulation of production of mucosal antibody to pneumococcal protein antigens by T-cell-derived gamma interferon and interleukin-10 in children.. https://www.ncbi.nlm.nih.gov/pubmed/16861661
Related Products
| Product Name | Product Code | Supplier | Accessory pack for ELISA set | 858.000.005 | Diaclone | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|